TG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52M [ad_2] Source link Post navigation Chevron raises yearly stock buyback target rate to $17.5 billion By Investing.com The Beauty Health Company to Acquire SkinStylus, FDA-Cleared Microneedling Device